evenfolio

FMCG · NSE: INDIAGLYCO

India Glycols

Q1 FY27 earnings and concall highlights

Price as of 16 Nov 2026
292.45−6.06%

Q1 FY27 earnings call · Guided by management

Call held 14 Aug 2026 · Read the filing on NSEFiling

₹500–0​CrEBITDA · IGL Spirits · FY27Rai · p. 8
₹400​CrEBITDA · Chemicals · next four to five yearsSarswat · p. 9
₹130–150​CrEBITDA · Ennature Bio Pharma · next four or five yearsSarswat · p. 10
₹400–500​CrPlant cost not expected · NSUSarswat · Q&A · p. 11
M.Cap
₹1,960Cr
P/E
7.1×
1Y return
−71.87%
From 52W high
−76.1%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q1 FY27, as filed · consolidated · ₹ Cr

Q1 FY27Q1 FY26YoYQ4 FY26QoQ
Revenue2,9882,503+19.4%2,360+26.6%
EBITDA170150+13.3%167+1.8%
EBITDA margin5.7%6.0%-31 bps7.1%-139 bps
PBTProfit before tax10272+42.2%99+2.8%
Net profit9773+32.2%87+11.5%
EPS (₹)14.4523.66-38.9%13.64+5.9%

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.

Guidance

Revenue · Chemicals · long termRs 2,500 CrChemicals aspiration: about Rs 2,500 crore business in four to five years
Revenue · NSU · FY27Rs 150-— CrNSU aspires to Rs 150 crore plus revenue this year
Revenue · NSU · long termRs 600-700 CrNSU aspires to be a Rs 600-700 crore business in 4 or 5 years
EBITDA · IGL Spirits · FY27Rs 500-— CrIGL Spirits expects FY27 EBITDA above Rs 500 crore
EBITDA · IGL Spirits · long termRs 1,000-— CrIGL Spirits targets EBITDA above Rs 1,000 crore in four to five years
EBITDA · Chemicals · long termRs 400 CrChemicals aspiration: about Rs 400 crore EBITDA in four to five years, not a projection
EBITDA · Ennature Bio Pharma · long termRs 130-150 CrEnnature aspires to Rs 130-150 crore EBITDA in four or five years
Gross margin · NSU · long term30%NSU gross margins expected closer to about 30% in 5 or 6 years
Capex · FY27Rs 5-20 CrNSU capex this year seen at about Rs 5-20 crore; not capex intensive

Amrut partnership: Aims to double Amrut whiskey volumes; single malt 10,000 plus volume in its states

Manoj Kumar Rai · Executive Director and COO (IGL Spirits Limited) · p. 7
“We are looking at doubling our volumes in the Amrut whiskey segment, the three whiskies that we make with them, we are looking at a healthy 10,000 plus kind of a volume as far as the single malt is concerned in the states where we operate.”

Potable Spirits: Potable spirits volume expected to double from last year

Manoj Rai · p. 11
“When I look at the volume, we are looking at doubling our volume from what we delivered last year.”

Potable Spirits: Potable spirits expected to grow in healthy double digits next year

Manoj Rai · p. 11
“The outlook for next year, we expect to continue to grow in healthy double digits.”

More figures from the call

Potable Spirits · Guidance
30–0​%IMFL share of revenue · FY27
“Percentage of revenue coming in from IMFL would be in excess of 30%.”
Manoj Kumar Rai · Executive Director and COO (IGL Spirits Limited) · Q&Ap. 16
Nicotine · Capacity
2​×Nicotine sales growth · Q1 FY27
“Nicotine sales grew two times quarter-over-quarter driven by customer conversions in Europe. Nicotine crude processing operations we also started in our Kashipur plant, adding significant capacity,”
Rupark Sarswat · Chief Executive Officerp. 10

In short

  1. 01IGL Spirits expects FY27 EBITDA above Rs 500 crore and targets above Rs 1,000 crore in four to five years.
  2. 02Q1 FY27 net revenue was Rs 1,130 crore, up 9%, with record EBITDA of Rs 170 crore; PAT rose 32%.
  3. 03NCLT sanctioned the demerger into three companies on 17 July 2026; effective date still to be communicated.
  4. 04Management says IGL Spirits would become debt-free from FY28 onwards.
  5. 05Aspirations, not projections: chemicals EBITDA about Rs 400 crore on about Rs 2,500 crore revenue, Ennature EBITDA Rs 130-150 crore, in four to five years.
  6. 06Spirits volume is expected to double in FY27; IMFL revenue grew 26% in Q1.
  7. 07Finance costs fell to Rs 25 crore from Rs 45 crore on debt reduction.
  8. 08The war raised raw material costs and hurt chemical exports to the Middle East, but helped ethylene oxide pricing.

Capex

NSU: About Rs 50-60 crore invested in new NSU plant additions so far

Rupark Sarswat · Chief Executive Officer · Q&A · p. 12
“And as far as new plant addition is concerned, we are probably talking about INR50 - 60 crores.”

NSU: NSU not capex intensive; modular expansion as businesses grow

Rupark Sarswat · Chief Executive Officer · Q&A · p. 11
“So, it is not a very capex intensive model as of now. But as our businesses grow, we will continue to have modular expansion.”

Segments

Spirits: Spirits revenue Rs 361 crore, up 5.3%; EBITDA up 14.2%

Rupark Sarswat · Chief Executive Officer · p. 4
“The Spirits business recorded a revenue of INR361 crores, up 5.3%, EBITDA growth of 14.2%,”

Chemicals: Chemicals revenue up 20.6% to Rs 362 crore on bio-glycols, green solvents, performance chemicals

Rupark Sarswat · Chief Executive Officer · p. 4
“In chemicals, our revenues increased by 20.6% to INR362 crores, driven by growth in multiple areas which include bio-glycols, green solvents, as well as performance chemicals.”

Bio-Fuel: Bio-Fuel revenue Rs 323 crore; EBIT up 19% to Rs 27 crore, EBIT margin 8.4%

Rupark Sarswat · Chief Executive Officer · p. 4
“Bio-Fuel reported a revenue of INR323 crores with EBIT increasing 19% year-on-year to INR27 crores and EBIT margin at 8.4%.”

Ennature Bio Pharma: Ennature Bio Pharma best-ever quarter: revenue up 65%, EBITDA up 188%

Rupark Sarswat · Chief Executive Officer · p. 4
“Ennature Bio Pharma reported its best-ever quarter with revenue rising 65% year-on-year and EBITDA increasing 188%.”

Chemicals: Growth expected from new performance chemicals; pipeline described as strong

Rupark Sarswat · Chief Executive Officer · p. 4
“We recognize that our growth will come from new performance chemicals, which right now is small, but I think the pipeline is strong and we expect it to continue to drive growth year-on-year.”

Demand

White spirits: White spirits growing fastest in IMFL; company expects a higher share there

Manoj Kumar Rai · Executive Director and COO (IGL Spirits Limited) · p. 7
“it's the white spirits business which is growing at the fastest pace, and we are strategically placed with our portfolio in this particular segment. We expect to garner a higher share in the segment.”

Chemicals: Collaborative partners include BASF, L'Oreal, Unilever and Mibelle

Rupark Sarswat · Chief Executive Officer · p. 9
“we've got strong collaborative partnership, not merely supply partnerships, are BASF, L'Oreal, Unilever, Mibelle, and many others”

Potable Spirits: Industry has grown at a 4% to 5% CAGR over the last two years

Manoj Rai · p. 11
“This is at a time when the industry last year or for the last two year has been showing a CAGR of 4% to 5%.”

Joint venture: JV pushing more exports from India to Clariant customers worldwide

Rupark Sarswat · Chief Executive Officer · Q&A · p. 12
“And what we also see is there is a greater thrust on exporting products made out of India into other Clariant customers worldwide.”

IMFL: IMFL industry in company's states declined or stayed flat

Manoj Kumar Rai · Executive Director and COO (IGL Spirits Limited) · p. 7
“Particularly in geographies where we are operating, the industry or the segment where we operate has either declined or remained stagnant.”

Margins and costs

Chemicals: Higher crude had a positive impact on the ethylene oxide business

Rupark Sarswat · Chief Executive Officer · p. 5
“So, as far as crude is concerned, it had a positive impact on our ethylene oxide business”

EBITDA margin rose from 9.6% in FY22 to 15.5% in FY26

Rupark Sarswat · Chief Executive Officer · p. 5
“if you look at FY22, we had an EBITDA margin of 9.6%, in FY23 it became 11.9%, in FY24 we achieved 12.9%, in FY25 13.9%, and in FY26 it was 15.5%.”

Consolidated EBITDA margin 15.0% vs 14.3% a year ago

Anand Singhal · Chief Financial Officer · p. 6
“EBITDA margin is 15.0% versus 14.3% in the Q1 last year.”

IGL Spirits: Captive ENA and spare capacity give a cost advantage and protect margins

Manoj Kumar Rai · Executive Director and COO (IGL Spirits Limited) · p. 7
“The fact that we have captive high-quality ENA and we have enough and more capacity available ensures that this gives us the cost advantage in the states that we operate and protects our margin.”

Joint venture: JV growth driven by smaller ethylene oxide pricing disadvantage

Rupark Sarswat · Chief Executive Officer · Q&A · p. 12
“So what has driven growth in the joint venture is the fact that the disadvantage on ethylene oxide pricing has been reduced because of the current scenario.”

Debt and working capital

Finance costs fell to Rs 25 crore from Rs 45 crore on debt reduction

Rupark Sarswat · Chief Executive Officer · p. 4
“The finance costs for the company declined to INR25 crores in Q1 FY27 from INR45 crores in Q1 FY26, and this is on account of debt reduction which has been supporting the profitable growth as well.”

Debt reduced during the quarter; debt-to-equity improved

Rupark Sarswat · Chief Executive Officer · p. 4
“Debt levels had reduced during the quarter and debt-to-equity ratio has also improved.”

IGL Spirits: IGL Spirits expects to become debt-free from FY28 onwards

Manoj Kumar Rai · Executive Director and COO (IGL Spirits Limited) · p. 8
“would eventually lead us to becoming a debt-free company from FY’28 onwards”

Acquisitions and new business

NCLT approval received for restructuring; effective date to be communicated

Rupark Sarswat · Chief Executive Officer · p. 4
“we've got the NCLT approval. Effective date is to be communicated,”

NCLT sanctioned the scheme on 17 July 2026; Spirits, Bio-Fuel and Bio Pharma move to new companies

Rupark Sarswat · Chief Executive Officer · p. 5
“As you know, NCLT has now sanctioned the scheme of arrangement on 17th of July 2026, and upon effectiveness, the Spirits, Bio-Fuel, and Bio Pharma undertaking transfer to dedicated resulting companies.”

India Glycols: India Glycols Limited keeps bio-based chemicals, specialty glycols, performance chemicals, gases

Rupark Sarswat · Chief Executive Officer · p. 5
“One entity remains as such, which is India Glycols Limited, as such in the sense of name, which will continue to have bio-based chemicals, specialty glycols, new performance chemicals, gases, and any other new areas in the chemical space we may get into.”

IGL Spirits: IGL Spirits Limited to hold potable spirits and the Bio-Fuel business

Rupark Sarswat · Chief Executive Officer · p. 6
“The other big one is IGL Spirits Limited, which will have the potable spirits business, both IMFL as well as Indian-made Indian liquor, but it also will have the Bio-Fuel business”

Ennature Bio Pharma: Biopolymers business moves from chemicals into Ennature Bio Pharma

Rupark Sarswat · Chief Executive Officer · p. 6
“but the biopolymers business from within the chemical business will now be part of this entity.”

Management

Gagan Kwatra joined to handle Investor Relations

Rupark Sarswat · Chief Executive Officer · p. 3
“First is the gentleman, Mr. Gagan Kwatra, who would be handling Investor Relations for us. He has joined us.”

Spirits and Ethanol: Manoj Kumar Rai joined as COO for the Spirits and Ethanol business

Rupark Sarswat · Chief Executive Officer · p. 3
“Mr. Manoj Kumar Rai, who has joined as the Chief Operating Officer for the Spirits and Ethanol business.”

One-offs

Q4 FY26 EBITDA included about Rs 39 crore Clariant dividend; none in Q1

Anand Singhal · Chief Financial Officer · Q&A · p. 15
“Last quarter ended 31st March '26 there was an income out of dividend from Clariant, which was about INR39 crores. So that's why in the last quarter the EBITDA was about INR203 crores.”

Risks

Westbound freight rose 5 to 20 times, hitting some businesses

Rupark Sarswat · Chief Executive Officer · p. 5
“So, freights for westbound cargos have been very, very volatile, going up anywhere between 5 to 20 times, which impacted some of our businesses.”

Chemicals: Raw materials like propylene oxide unavailable or too costly; Middle East oil and gas sales collapsed

Rupark Sarswat · Chief Executive Officer · p. 5
“we also supply oil and gas materials to the Middle East which essentially completely collapsed because there was no sale happening to that area, and also shipments to US etcetera became very difficult.”

Ennature Bio Pharma: Ennature raw material availability and pricing volatile, a challenge in Q2 too

Rupark Sarswat · Chief Executive Officer · p. 10
“However, the raw material availability and pricing continue to be volatile and a challenge in Q2 as well.”

Chemicals: Raw materials such as propylene oxide unavailable or too costly

Rupark Sarswat · Chief Executive Officer · p. 5
“several of our raw materials, propylene oxide for example, were either completely not available or were prohibitively expensive.”

Other

Q1 FY27 net revenue Rs 1,130 crore, up 9%; record EBITDA of Rs 170 crore

Rupark Sarswat · Chief Executive Officer · p. 4
“we've had net revenue of INR1,130 crores, up 9% and a record EBITDA of INR170 crores.”

Q1 gross revenue up 19%, net revenue up 9%, EBITDA up 13%, PAT up 32%

Rupark Sarswat · Chief Executive Officer · p. 4
“our gross revenue is up 19%, net revenue up 9%, EBITDA up 13% and PAT up 32%.”

IGL Spirits: Only company in India with an exclusive spirit maturation facility for Bacardi

Manoj Kumar Rai · Executive Director and COO (IGL Spirits Limited) · p. 7
“we are the only one in the country which has exclusive facility for them in terms of spirit maturation.”

IGL Spirits: Says it would then probably be among India's top five alco-bev companies

Manoj Kumar Rai · Executive Director and COO (IGL Spirits Limited) · p. 8
“If we do this, we would probably be one of the top five alco-bev companies in this country.”

Clariant dividend income comes only in the last quarter; none in Q1

Anand Singhal · Chief Financial Officer · Q&A · p. 15
“In the current quarter since there is no dividend income because all dividend income comes in the last quarter. So that's why this quarter we have this EBITDA of INR170 crores.”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools